JP2019516981A5 - - Google Patents

Download PDF

Info

Publication number
JP2019516981A5
JP2019516981A5 JP2018559285A JP2018559285A JP2019516981A5 JP 2019516981 A5 JP2019516981 A5 JP 2019516981A5 JP 2018559285 A JP2018559285 A JP 2018559285A JP 2018559285 A JP2018559285 A JP 2018559285A JP 2019516981 A5 JP2019516981 A5 JP 2019516981A5
Authority
JP
Japan
Prior art keywords
biomarkers
pancreatic cancer
biomarkers listed
amount
listed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018559285A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019516981A (ja
Filing date
Publication date
Priority claimed from GBGB1608192.9A external-priority patent/GB201608192D0/en
Application filed filed Critical
Publication of JP2019516981A publication Critical patent/JP2019516981A/ja
Publication of JP2019516981A5 publication Critical patent/JP2019516981A5/ja
Priority to JP2021106544A priority Critical patent/JP2021165745A/ja
Pending legal-status Critical Current

Links

JP2018559285A 2016-05-10 2017-05-10 方法、アレイ、およびその使用 Pending JP2019516981A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021106544A JP2021165745A (ja) 2016-05-10 2021-06-28 方法、アレイ、およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1608192.9A GB201608192D0 (en) 2016-05-10 2016-05-10 Method, array and use thereof
GB1608192.9 2016-05-10
PCT/EP2017/061202 WO2017194613A2 (en) 2016-05-10 2017-05-10 Method, array and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021106544A Division JP2021165745A (ja) 2016-05-10 2021-06-28 方法、アレイ、およびその使用

Publications (2)

Publication Number Publication Date
JP2019516981A JP2019516981A (ja) 2019-06-20
JP2019516981A5 true JP2019516981A5 (enExample) 2020-06-25

Family

ID=56297465

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018559285A Pending JP2019516981A (ja) 2016-05-10 2017-05-10 方法、アレイ、およびその使用
JP2021106544A Pending JP2021165745A (ja) 2016-05-10 2021-06-28 方法、アレイ、およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021106544A Pending JP2021165745A (ja) 2016-05-10 2021-06-28 方法、アレイ、およびその使用

Country Status (13)

Country Link
US (2) US20200011872A1 (enExample)
EP (2) EP3907509A3 (enExample)
JP (2) JP2019516981A (enExample)
KR (1) KR20190005858A (enExample)
CN (1) CN109564221A (enExample)
AU (1) AU2017261762A1 (enExample)
BR (1) BR112018073178A2 (enExample)
CA (1) CA3022022A1 (enExample)
GB (1) GB201608192D0 (enExample)
IL (1) IL262824A (enExample)
MX (1) MX2018013621A (enExample)
RU (1) RU2018138639A (enExample)
WO (1) WO2017194613A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2442919T3 (es) * 2007-03-27 2014-02-14 Immunovia Ab Firma/marcadores de proteínas para la detección de adenocarcinoma
AU2018273914A1 (en) 2017-05-24 2019-11-14 Pandion Operations, Inc. Targeted immunotolerance
US10946068B2 (en) 2017-12-06 2021-03-16 Pandion Operations, Inc. IL-2 muteins and uses thereof
US10174091B1 (en) 2017-12-06 2019-01-08 Pandion Therapeutics, Inc. IL-2 muteins
TW202110885A (zh) 2019-05-20 2021-03-16 美商潘迪恩治療公司 靶向MAdCAM之免疫耐受性
WO2021168079A1 (en) 2020-02-21 2021-08-26 Pandion Operations, Inc. Tissue targeted immunotolerance with a cd39 effector
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
EP4247434A4 (en) * 2020-11-18 2024-10-23 Pandion Operations, Inc. THERAPEUTIC AGENTS TARGETING MADCAM AND THEIR USES
CA3202255A1 (en) 2020-12-21 2022-06-30 Hayley WARSINSKE Markers for the early detection of colon cell proliferative disorders
WO2022204332A1 (en) * 2021-03-24 2022-09-29 Combangio, Inc. Compositions comprising c-met agonist antibodies and methods for use in ocular treatment
CN117305244B (zh) * 2023-03-28 2025-02-28 湖南省肿瘤医院 人胰腺癌细胞株及其应用
CN120177800B (zh) * 2025-05-23 2025-10-10 四川大学 血液生物标志物cfp在制备急性胰腺炎诊断试剂的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039578B1 (en) 1980-05-02 1985-04-10 Edward P. Davis Leg aid device
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
DE60325541D1 (de) * 2002-10-31 2009-02-12 Hoffmann La Roche Verfahren/Präparat zur Erkennung von Pankreaskrebs
US9005613B2 (en) * 2003-06-16 2015-04-14 Immunomedics, Inc. Anti-mucin antibodies for early detection and treatment of pancreatic cancer
WO2007013360A2 (en) * 2005-07-27 2007-02-01 Oncotherapy Science, Inc. Pancreatic cancer related gene cst6 and gabrp
ES2442919T3 (es) * 2007-03-27 2014-02-14 Immunovia Ab Firma/marcadores de proteínas para la detección de adenocarcinoma
CN106198980B (zh) * 2010-08-13 2018-09-07 私募蛋白质体公司 胰腺癌生物标记及其用途
GB201103726D0 (en) 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
WO2013052480A1 (en) * 2011-10-03 2013-04-11 The Board Of Regents Of The University Of Texas System Marker-based prognostic risk score in colon cancer
US20150018235A1 (en) * 2012-01-13 2015-01-15 Oncocyte Corporation Methods and Compositions for the Treatment and Diagnosis of Pancreatic Cancer
KR20140094180A (ko) * 2013-01-21 2014-07-30 연세대학교 산학협력단 보체인자 b 단백질에 특이적으로 결합하는 폴리펩타이드 또는 항체를 포함하는 췌장암 진단용 조성물
WO2014160499A2 (en) * 2013-03-13 2014-10-02 Creatics Llc Methods and compositions for detecting pancreatic cancer
CN105102637B (zh) * 2013-04-17 2018-05-22 Lg电子株式会社 提取胰腺癌诊断生物标志物的方法、用于该方法的计算装置、胰腺癌诊断生物标志物以及包含该生物标志物的胰腺癌诊断装置
DK3054298T3 (en) * 2013-10-01 2019-04-08 Toray Industries METHOD OF DETECTING TUMOR IN THE ARC
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
WO2015171736A2 (en) * 2014-05-07 2015-11-12 University Of Utah Research Foundation Biomarkers and methods for diagnosis of early stage pancreatic ductal adenocarcinoma
KR20150129932A (ko) * 2014-05-12 2015-11-23 연세대학교 산학협력단 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트
CN105092845A (zh) * 2015-07-10 2015-11-25 深圳市贝沃德克生物技术研究院有限公司 胰腺癌蛋白生物标记物、用途及其检测芯片和检测装置
GB201516801D0 (en) * 2015-09-22 2015-11-04 Immunovia Ab Method, array and use thereof

Similar Documents

Publication Publication Date Title
JP2019516981A5 (enExample)
JP7194128B2 (ja) 固形腫瘍の診断用のバイオマーカーの絶対定量の方法および装置
US20190219578A1 (en) Dectection of exosomes and exosomal biomarkers for the diagnosis and prognosis of diseases and disorders
CN107110867B (zh) 用于肝癌诊断的生物标记物及其用途
WO2018218090A1 (en) Detection of biomarkers on vesicles for the diagnosis and prognosis of diseases and disorders
CN105556308B (zh) 用于阑尾炎的诊断和预后及腹痛病因的区分的方法和组合物
Fredolini et al. Immunocapture strategies in translational proteomics
RU2018138639A (ru) Способ, чип и их применение
JP2010522875A5 (enExample)
JP2016537652A5 (enExample)
US20120295814A1 (en) CA-125 Immune Complexes as Biomarkers of Ovarian Cancer
CN103826662A (zh) 评估急性肾损伤等级的方法和试剂
CN103688173A (zh) 肌炎
JP2020507760A5 (enExample)
CN108780079A (zh) 不稳定型心绞痛的诊断
Kukova et al. Comparison of urine and plasma biomarker concentrations measured by aptamer-based versus immunoassay methods in cardiac surgery patients
JP2014512014A (ja) 川崎病の診断マーカーおよび治療標的
KR20120004990A (ko) 관절염 상태를 특성화하는 조성물 및 방법
JP2016519767A5 (enExample)
JP2023551327A (ja) 血液由来エクソソームから見出した新規アルツハイマー病診断用バイオマーカー及びそれを用いたアルツハイマー病診断方法
RU2019110953A (ru) Моноклональное антитело, специфически связывающееся с тиоредоксином-1, и его применение
JP2014505251A (ja) Bcl−2様タンパク質11のSRM/MRMアッセイ
US20140141449A1 (en) Autoantibody Biomarkers for IGA Nephropathy
CN102753973B (zh) Ku86和其自身抗体的复合物的免疫测定方法、及其中使用的试剂盒
AU2016297676B2 (en) Biomarker combinations for prostate disease